Asset Details
Do you wish to reserve the book?
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate version 1; peer review: 2 approved with reservations
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate version 1; peer review: 2 approved with reservations
Do you wish to request the book?
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate version 1; peer review: 2 approved with reservations
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate version 1; peer review: 2 approved with reservations
2022
Overview
Background: This study aims to determine the factors affecting HBV DNA suppression in chronic hepatitis B patients with tenofovir disoproxil fumarate (TDF).
Methods: A case-control was carried out from October 2021 to August 2022 on 182 chronic hepatitis B patients who had TDF therapy regularly for 24 weeks at H. Adam Malik and USU Hospitals in Medan, Indonesia. The history of the samples was obtained, followed by physical examination, and blood collection. CTLA-4 polymorphism examination was carried out using real-time PCR, while the serum CTLA-4 levels were assessed with ELISA.
Results: The results showed that CTLA-4, HBV DNA, ALT, and CTLA-4 -1661G>A polymorphisms have a relationship with HBV DNA suppression in chronic hepatitis B patients with TDF.
Conclusions: The levels of CTLA-4, HBV DNA, ALT, and CTLA-4 -1661G>A polymorphism have a potential relationship with the suppression of HBV DNA in chronic hepatitis B patients with TDF.
We currently cannot retrieve any items related to this title. Kindly check back at a later time.